Clincial Trials match your criteria
-
Inotuzumab Ozogamicin/Chemo in B Acute Lymphoblastic Leukemia
A PHASE III TRIAL TO EVALUATE THE EFFICACY OF THE ADDITION OF INOTUZUMAB OZOGAMICIN (A CONJUGATED ANTI-CD22 MONOCLONAL ANTIBODY) TO FRONTLINE THERAPY IN YOUNG ADULTS (AGES 18-39 YEARS) WITH NEWLY DIAGNOSED PRECURSOR B-CELL ALL
-
Pediatric Hepatic Malignancy International Therapeutic Trial
Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
-
Web-Based Physical Activity Intervention to Improve Health in Children with Leukemia
A Randomized Web-based Physical Activity Intervention among Children and Adolescents with Acute Lymphoblastic Leukemia
-
MERIT TrialMulti-center ESG Randomized Interventional Trial for the treatment of obesity
Multi-center ESG Randomized Interventional Trial (MERIT-Trial)
-
CONNECT-HF
CARE OPTIMIZATION THROUGH PATIENT AND HOSPITAL ENGAGEMENT CLINICAL TRIAL FOR HEART FAILURE—CONNECT-HF
-
tDNA Registry
Circulating tumor DNA exposure in peripheral blood using a novel process: A feasibility study
-
Study of nivolumab and relatilimab for untreated melanoma patients
A Randomized, Double-blind Phase 2/3 Study of Relatlimab Combined with Nivolumab versus Nivolumab in Participants with Previously Untreated Metastatic or Unresectable Melanoma
-
Airway microbiome, nasal microRNA, and age 6-year asthma phenotypes in the MARC-35 cohort.
Airway microbiome, nasal microRNA, and age 6-year asthma phenotypes in the MARC-35 cohort.
-
Neoadjuvant therapy for abnormal HER2- Signaling
An Open-Label Phase II Trial to Evaluate the Efficacy and Safety of Neoadjuvant Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel Plus Trastuzumab and Pertuzumab in Early Stage HER2-Negative Breast Cancer Patients Selected with a Test Measuring Live Cell HER2 Signaling Transduction (FACT 1)
-
A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children
A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial (enliGHten)
